Published in Otolaryngol Head Neck Surg on August 22, 2011
Circulating mutant DNA to assess tumor dynamics. Nat Med (2007) 10.33
Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med (2014) 8.36
S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol (2005) 7.25
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S A (2013) 6.88
Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA (2013) 5.71
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab (2005) 4.39
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget (2012) 3.88
Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science (2011) 3.49
p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron (2005) 3.13
BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol (2009) 3.02
Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma. Cancer Res (2013) 2.81
Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers. Sci Transl Med (2013) 2.58
Objective assessment in residency-based training for transoral robotic surgery. Laryngoscope (2012) 2.06
Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon. Head Neck (2008) 1.97
Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid (2009) 1.90
GOSPEL: a neuroprotective protein that binds to GAPDH upon S-nitrosylation. Neuron (2009) 1.83
Targeting vascular and avascular compartments of tumors with C. novyi-NT and anti-microtubule agents. Cancer Biol Ther (2004) 1.71
Selective growth inhibition in BRAF mutant thyroid cancer by the mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244. J Clin Endocrinol Metab (2007) 1.66
Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil. Proc Natl Acad Sci U S A (2005) 1.65
Human papillomavirus-related carcinomas of the sinonasal tract. Am J Surg Pathol (2013) 1.63
Is routine dissection of level II-B and V-A necessary in patients with papillary thyroid cancer undergoing lateral neck dissection for FNA-confirmed metastases in other levels. World J Surg (2009) 1.59
American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid (2012) 1.57
Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer. Int J Cancer (2006) 1.56
Application of the hybrid capture 2 assay to squamous cell carcinomas of the head and neck: a convenient liquid-phase approach for the reliable determination of human papillomavirus status. Cancer Cytopathol (2011) 1.54
Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer. J Clin Endocrinol Metab (2004) 1.54
Malignant odontogenic tumors: a 22-year experience. Laryngoscope (2004) 1.53
Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res (2002) 1.53
Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules. Clin Cancer Res (2004) 1.47
Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination. Cancer Res (2007) 1.43
The impact of molecular testing on the surgical management of patients with thyroid nodules. Ann Surg Oncol (2014) 1.43
Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy. J Nucl Med (2007) 1.41
Long-term oral intake through a salivary bypass tube with chronic pharyngocutaneous fistula. Am J Otolaryngol (2012) 1.40
Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery. Vaccine (2009) 1.38
American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma. Thyroid (2012) 1.36
Ameloblastic carcinoma of the maxilla. Oral Oncol (2003) 1.34
Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria. Proc Natl Acad Sci U S A (2003) 1.34
FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma. Imaging Med (2012) 1.32
Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. Laryngoscope (2009) 1.27
The impact of surgical volume on patient outcomes following thyroid surgery. Surgery (2013) 1.22
Activation of Akt as a mechanism for tumor immune evasion. Mol Ther (2008) 1.22
American Thyroid Association statement on outpatient thyroidectomy. Thyroid (2013) 1.22
Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS. J Clin Endocrinol Metab (2012) 1.21
Human papillomavirus-related carcinoma with adenoid cystic-like features: a peculiar variant of head and neck cancer restricted to the sinonasal tract. Am J Surg Pathol (2013) 1.19
Volume-based trends in thyroid surgery. Arch Otolaryngol Head Neck Surg (2010) 1.19
Exomic sequencing of four rare central nervous system tumor types. Oncotarget (2013) 1.17
Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET/CT. PLoS One (2007) 1.15
Activation of the NOTCH pathway in head and neck cancer. Cancer Res (2013) 1.15
Pharmacologic and toxicologic evaluation of C. novyi-NT spores. Toxicol Sci (2005) 1.14
HPV analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. Am J Surg Pathol (2012) 1.14
Postoperative hypocalcemia after thyroidectomy for Graves' disease. Thyroid (2010) 1.12
Odontogenic ghost cell carcinoma. Head Neck (2004) 1.12
The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma. Laryngoscope (2005) 1.12
Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine. Cancer Immunol Immunother (2012) 1.10
Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma. Cancer Epidemiol Biomarkers Prev (2002) 1.09
Safety of robotic thyroidectomy approaches: meta-analysis and systematic review. Head Neck (2013) 1.07
Identification of genes differentially expressed in benign versus malignant thyroid tumors. Clin Cancer Res (2008) 1.05
The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2006) 1.01
Langerhans cell histiocytosis of the thyroid gland. Am J Otolaryngol (2008) 1.01
What is the best definitive treatment for Graves' disease? A systematic review of the existing literature. Ann Surg Oncol (2012) 1.01
Transoral robotic-assisted thyroidectomy: a preclinical feasibility study in 2 cadavers. Head Neck (2011) 1.01
Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7R. Cancer Res (2004) 0.99
Image-guided transnasal endoscopic resection of an orbital solitary fibrous tumor. Ophthal Plast Reconstr Surg (2008) 0.99
Ectopic expression of X-linked lymphocyte-regulated protein pM1 renders tumor cells resistant to antitumor immunity. Cancer Res (2010) 0.99
Motor and sensory branching of the recurrent laryngeal nerve in thyroid surgery. Surgery (2011) 0.98
Comprehensive review of small bowel metastasis from head and neck squamous cell carcinoma. Oral Oncol (2010) 0.97
The utility of evaluating true vocal fold motion before thyroid surgery. Laryngoscope (2006) 0.97
Surgical management of posterior epistaxis: a changing paradigm. Laryngoscope (2002) 0.96
Dual inhibition of RET and FGFR4 restrains medullary thyroid cancer cell growth. Clin Cancer Res (2005) 0.95
Incidence of malignancy in thyroid nodules determined to be follicular lesions of undetermined significance on fine-needle aspiration. World J Surg (2012) 0.94
The role of pre-operative CT-guided FNAB for parapharyngeal space tumors. Otolaryngol Head Neck Surg (2007) 0.94
Long-term prognosis and risk factors among patients with HPV-associated oropharyngeal squamous cell carcinoma. Cancer (2013) 0.94
National trends in thyroid surgery and the effect of volume on short-term outcomes. Laryngoscope (2013) 0.93
Enhanced cancer radiotherapy through immunosuppressive stromal cell destruction in tumors. Clin Cancer Res (2013) 0.92
A safe and cost-effective short hospital stay protocol to identify patients at low risk for the development of significant hypocalcemia after total thyroidectomy. Laryngoscope (2006) 0.92
Anatomical anomalies of the laryngeal branches of the vagus nerve in pigs (Sus scrofa). Lab Anim (2012) 0.92
Solitary fibrous tumor of the thyroid gland. Laryngoscope (2009) 0.91
Superior laryngeal nerve quantitative intraoperative monitoring is possible in all thyroid surgeries. Laryngoscope (2014) 0.91
Epidemiology of head and neck squamous cell cancer among HIV-infected patients. J Acquir Immune Defic Syndr (2014) 0.90
Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer. Laryngoscope (2006) 0.90
In-situ tumor vaccination: Bringing the fight to the tumor. Hum Vaccin Immunother (2015) 0.90
Survival implications of cervical lymphadenectomy in patients with medullary thyroid cancer. Ann Surg Oncol (2010) 0.90
A comparative North American experience of robotic thyroidectomy in a thyroid cancer population. Langenbecks Arch Surg (2013) 0.89
Intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma. Arch Otolaryngol Head Neck Surg (2009) 0.89
Transoral robotic-assisted thyroidectomy with central neck dissection: preclinical cadaver feasibility study and proposed surgical technique. J Robot Surg (2011) 0.89
Management considerations for differentiated thyroid carcinoma presenting as a metastasis to the skull base. Laryngoscope (2007) 0.89
Use of the GlideScope for placement of a recurrent laryngeal nerve monitoring endotracheal tube. J Clin Anesth (2011) 0.89
Factors associated with pharyngoesophageal stricture in patients treated with concurrent chemotherapy and radiation therapy for oropharyngeal squamous cell carcinoma. Head Neck (2011) 0.89
Lessons learned from next-generation sequencing in head and neck cancer. Head Neck (2012) 0.88
Combination of viral oncolysis and tumor-specific immunity to control established tumors. Clin Cancer Res (2009) 0.88
Immunotherapy for head and neck cancer. J Biomed Sci (2008) 0.88
The role of the robotic-assisted transaxillary gasless approach for the removal of parathyroid adenomas. ORL J Otorhinolaryngol Relat Spec (2014) 0.88
Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg (2012) 0.87
Algorithm for safe and effective reoperative thyroid bed surgery for recurrent/persistent papillary thyroid carcinoma. Head Neck (2007) 0.87